Press release
Society for Clinical Trials Selects India’s “Jharkhand and Orissa” trial as “Trial of the Year”
PHILADELPHIA — “The Ekjut Trial in Jharkhand and Orissa” earns recognition as “Trial of the Year” by the Society for Clinical Trials (SCT) as an extraordinary randomized clinical trial, conducted with high quality in a very difficult setting, and achieving dramatic results of great public health importance. The trial’s principal investigator, Dr. Prasanta Tripathy, will present an overview of the trial methods and findings during the SCT’s 2011 Annual Meeting in Vancouver, BC, Canada on Tuesday, May 17.Each year since 2008, the SCT has teamed with Project ImpACT to present an award to the randomized clinical trial published (either electronically or in print) in the previous year that best fulfills the following standards:
• It improves the lot of mankind.
• It provides the basis for a substantial, beneficial change in health care.
• It reflects expertise in subject matter, excellence in methodology, and concern for study participants.
• It overcomes obstacles in implementation.
• The presentation of its design, execution, and results is a model of clarity and intellectual soundness.
Published in The Lancet in March 2010 [Lancet 2010;375: 1182-92], the “Jharkhand and Orissa” trial was a cluster randomized trial in very poor communities in eastern India. The goal of this study was to reduce neonatal mortality rates and maternal depression. The investigators successfully randomized 36 districts to a community intervention (vs. none) which involved using or organizing village women’s groups, who engaged in participatory learning and action through play, stories and games. Group members themselves identified newborn health problems within the community and selected their own strategies to address the problems, which they then implemented. After three years of the intervention, neonatal mortality was reduced by 45% and maternal depression by 57%.
Nominations for “Trial of the Year” came from SCT members, investigators, and interested scholars from around the world. The selection committee, headed by David Sackett of the Trout Research and Education Centre in Canada, included Kay Dickersin of Johns Hopkins Bloomberg School of Public Health, Kyungman Kim of University of Wisconsin, Steve Goodman of Johns Hopkins University and editor of Clinical Trials, and John Norrie of University of Glasgow. The committee was extremely pleased with the quality of nominations, reducing a slate of nine down to three finalists. The “Jharkhand and Orissa” trial stood out among its competition because, noted committee member Dr. Goodman, “Perhaps most importantly, the study gave the participants and their communities tools to continue the intervention after the study was over.”
Dr. Prasanta Tripathy will travel from India to present the study and represent the organization Ekjut (www.ekjutindia.org), whose mission it is to improve maternal and neonatal outcomes in the poorest areas of India. He explains that “ekjut” means ‘together’ in several Indian languages.
“This potential for continuation after the official end of the study was something that we thought about before the study began,” explained Dr. Tripathy. “We also agreed to extend the benefits of the intervention to the control areas if the intervention had an impact. We secured financial resources for the same, providing support to the groups through ‘facilitators’ from the same community and also disseminating findings for a possible roll-out by government.”
Dr. Anthony Costello, of the University College London Centre for International Health and Development, Institute of Child Health, was a co-investigator on this study. He further explains the value of such a trial in the developing world: “The trial was designed as a community effectiveness trial rather than an efficacy trial of a perfectly implemented intervention which would be difficult to scale up in the real and resource-limited world in which these tribal populations live. Such trials are essential in the developing world so that we can really estimate the impact and cost-effectiveness of what we do.”
The “Jharkhand and Orissa” trial is an example of the sometimes vague concept of clinical trials being made relevant in the “real world.” As Dr. Tripathy illustrates, “This trial was a community-based intervention where we were testing the impact of a ‘process of change.’ It is recommended that such RCTs should also be accompanied by process evaluation, explaining the context, methods, how the intervention was carried out and possible mechanisms of change in the partnering communities so that the intervention can be adapted for scaling up in other locations keeping the ‘real world’ in mind. We have, therefore, published a process evaluation paper to explain the impact: [Explaining the impact of a women's group led community mobilisation intervention on maternal and newborn health outcomes: the Ekjut trial process evaluation-Rath et al., BMC International Health and Human Rights 2010, 10:25doi:10.1186/1472-698X-10-25]. We have also scaled up our work with women’s groups to newer settings in eight districts of Jharkhand and Orissa states of India to gauge the impact.”
###
Note to Editors: Journalists wishing to attend the presentation by Dr. Tripathy on Tuesday, May 17, 2011 at 5:00 PM should contact the Society’s headquarters office at +1.215.564.3484, x 2213. A proof of assignment and photo ID will be requested.
About the Society for Clinical Trials: The Society for Clinical Trials, created in 1978, is an international professional organization dedicated to the development and dissemination of knowledge about the design, conduct and analysis of government and industry-sponsored clinical trials and related health care research methodologies. Visit www.sctweb.org.
About Project ImpACT: The aim of Project ImpACT (Important Achievements of Clinical Trials) is to identify and develop a comprehensive description of the most important randomized controlled trials (RCTs) performed in the fields of medicine and public health since 1948. Learn more at http://www.projectimpact.info/Home/.
Download Photos: View photos from Jharkhand and Orissa trial on the SCT website. Please provide photo credit to: Ekjut, Chakradharpur, Jharkhand, India, 2010.
About the Trial of the Year: Find a list of past Trials of the Year on the SCT website.
We are a unique international organization dedicated to the development and dissemination of knowledge about the design, conduct and analysis of clinical trial methodologies. Working towards these goals, in our Society you will find physicians, nurses, data managers, programmers, statisticians, coordinators, epidemiologists, policy experts, ethicists, regulators, and others who identify themselves as trialists.
Society for Clinical Trials
c/o Fernley & Fernley
100 N 20th Street, 4th Floor
Philadelphia, PA 19103 USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Society for Clinical Trials Selects India’s “Jharkhand and Orissa” trial as “Trial of the Year” here
News-ID: 168594 • Views: …
More Releases from Society for Clinical Trials
Hindus welcome showcasing of Bhagavata-Purana by San Diego Museum of Art
NewsPatrolling.com: The San Diego Museum of Art (SDMA) is presenting “Epic Tales from Ancient India” exhibition of world-renowned over 90 paintings of 16th-19th centuries from June nine through September three.
It includes depictions from Hindu texts Bhagavata-Purana and Ramayana, and Ragamala. The exhibition also includes an interactive performance space to bring the narratives to life through hands-on workshops, musical performances, dance, educational storytelling and more; Museum announcement says.
Activities associated…
Oxford Dictionaries is delighted to announce the inaugural Hindi Word of the Yea …
NewsPatrolling.com / Niryas.com :The Hindi Word of the Year is a word or expression that has attracted a great deal of attention and reflects the ethos, mood, or preoccupations of the past year.
‘Aadhaar’ is a word long established in the Hindi language. However, it gained a new sense in 2010 as the shorthand name for the Aadhaar Card i.e. Unique Identification Numbers (UIN) introduced by the then…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…